DAY 3

Session 9: How future regulations could support vaccines' release paradim's chage
Moderators: Corrinne Philippe, Boehringer Ingelheim, France

Panel Discussion
Dianliang LEI & Alain FAUCONNIER, WHO, Switzerland
Luca Porfiri, FAO, Thailand
Laure MARTINEZ, Virbac, France
Charles SANDY, AUDA-NEPAD, South Africa
Meenu BATOLAR, CEPI, Singapore
Dean SMITH, IABS, Canada

Session 10: Future outlook on vaccines development, manufacturing and release strategies. How NAM's are going to change the field
Moderators: Colleen Pike, Humane World for Animals, USA

The Pre-clinical (and clinical) Utilities of Microphysiological Systems as in Vitro NAMs in Drug and Vaccine Development
Danilo TAGLE
NIH (remote), USA

Slide

EU initiatives to advance NAMs in research and regulatory testing 
Ole OLESEN
Independent Expert, Belgium

Slide

Panel Discussion
Danilo TAGLE, NIH (remote), USA
Ole OLESEN, Independent Expert, Belgium
Gautam SANYAL, Vaccine Analytics, USA
Dean SMITH, IABS, Canada
Lorenzo TESOLIN, Sciensano, Belgium

Closing Remarks
Joris VANDEPUTTE, IABS, Belgium
Laura VIVIANI, SciEthiQ for Humane World for Animals and AFSA, Italy